SCHEMBL7399079

SCHEMBL7399079

O=C(N[C@@H](Cc1ccc(CO)cc1)C(=O)O)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 9/20 0.64
ITGA2B P08514 9/20 0.64
TACR1 P25103 2/20 0.61
CTSL P07711 1/20 0.60
CTSB P07858 1/20 0.60
CTSS P25774 1/20 0.60
CTSK P43235 1/20 0.60
ALDH1A1 P00352 1/20 0.58
ALOX15 P16050 1/20 0.58
CTRB1 P17538 2/20 0.57
MME P08473 1/20 0.57
ECE1 P42892 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7399084 1.00 ITGB3 (0.64) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL479010 0.93 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL26661077 0.93 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL7372270 0.93 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL220648 0.93 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL219151 0.93 TACR1 (0.68) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL10507966 0.90 ECE1 (0.65) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL5401365 0.90 ITGB3 (0.65) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL1702159 0.90 ECE1 (0.65) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL5391083 0.90 ITGB3 (0.65) ITGB3ITGA2BTACR1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106898-A1 METHODS AND SYSTEMS FOR PREPARING IRREVERSIBLE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2011-09-09 WO disclosed
WO-1992014706-A1 CYCLOPENTANE-DERIVED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS PFIZER LIMITED (GB) 1992-09-03 WO disclosed